Anticancer treatment and thrombosis
A Falanga, M Marchetti - Thrombosis research, 2012 - Elsevier
Venous thromboembolic (VTE) complications are common in patients with cancer and
represent the second cause of death in this disease. The risk of VTE varies according to the …
represent the second cause of death in this disease. The risk of VTE varies according to the …
Anticancer treatment and thrombosis
A Falanga, M Marchetti - Thrombosis Research, 2012 - thrombosisresearch.com
Venous thromboembolic (VTE) complications are common in patients with cancer and
represent the second cause of death in this disease. The risk of VTE varies according to the …
represent the second cause of death in this disease. The risk of VTE varies according to the …
Anticancer treatment and thrombosis
A Falanga, M Marchetti - Thrombosis Research, 2012 - infona.pl
Venous thromboembolic (VTE) complications are common in patients with cancer and
represent the second cause of death in this disease. The risk of VTE varies according to the …
represent the second cause of death in this disease. The risk of VTE varies according to the …
Anticancer treatment and thrombosis
A Falanga, M Marchetti - Thrombosis research, 2012 - pubmed.ncbi.nlm.nih.gov
Venous thromboembolic (VTE) complications are common in patients with cancer and
represent the second cause of death in this disease. The risk of VTE varies according to the …
represent the second cause of death in this disease. The risk of VTE varies according to the …
Anticancer treatment and thrombosis.
A Falanga, M Marchetti - Thrombosis Research, 2011 - europepmc.org
Venous thromboembolic (VTE) complications are common in patients with cancer and
represent the second cause of death in this disease. The risk of VTE varies according to the …
represent the second cause of death in this disease. The risk of VTE varies according to the …
[PDF][PDF] Anticancer treatment and thrombosis
A Falanga, M Marchetti - Thrombosis Research, 2012 - researchgate.net
Venous thromboembolism (VTE) is a common complication in cancer patients which
significantly impacts on mortality and quality of life of the affected subjects [1]. Indeed …
significantly impacts on mortality and quality of life of the affected subjects [1]. Indeed …
[引用][C] Anticancer treatment and thrombosis
A FALANGA, M MARCHETTI - Thrombosis research, 2012 - pascal-francis.inist.fr
Anticancer treatment and thrombosis CNRS Inist Pascal-Francis CNRS Pascal and Francis
Bibliographic Databases Simple search Advanced search Search by classification Search …
Bibliographic Databases Simple search Advanced search Search by classification Search …
[PDF][PDF] Anticancer treatment and thrombosis
A Falanga, M Marchetti - Thrombosis Research, 2012 - academia.edu
Venous thromboembolism (VTE) is a common complication in cancer patients which
significantly impacts on mortality and quality of life of the affected subjects [1]. Indeed …
significantly impacts on mortality and quality of life of the affected subjects [1]. Indeed …
[引用][C] Anticancer treatment and thrombosis
A Falanga, M Marchetti - Thrombosis Research, 2012 - cir.nii.ac.jp
Anticancer treatment and thrombosis | CiNii Research CiNii 国立情報学研究所 学術情報
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本をさがす …
[PDF][PDF] Anticancer treatment and thrombosis
A Falanga, M Marchetti - Thrombosis Research, 2012 - academia.edu
Venous thromboembolism (VTE) is a common complication in cancer patients which
significantly impacts on mortality and quality of life of the affected subjects [1]. Indeed …
significantly impacts on mortality and quality of life of the affected subjects [1]. Indeed …